Glenmark Pharmaceuticals consolidated net profit declines 4.24% in the September 2017 quarter

Sales rise 2.31% to Rs 2223.44 crore

Net profit of Glenmark Pharmaceuticals declined 4.24% to Rs 214.12 crore in the quarter ended September 2017 as against Rs 223.59 crore during the previous quarter ended September 2016. Sales rose 2.31% to Rs 2223.44 crore in the quarter ended September 2017 as against Rs 2173.18 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales2223.442173.18 2 OPM %17.4720.65 -PBDT348.28384.06 -9 PBT273.05315.36 -13 NP214.12223.59 -4

Powered by Capital Market - Live News